A randomized phase III trial comparing triple weekly usage with weekly usage of paclitaxel in concurrent chemoradiotherapy for patients with locally advanced non-small cell lung cancer.

被引：0
|
作者：
Zhu, Guangying
Shi, Anhui
Lin, Hongmei
Chen, Yuhchyau
Yu, Rong
Li, Jian-Cheng
Li, Hang
Wang, Yingjie
Xia, Tingyi
Feng, Linchun
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Radiat Oncol, Minist Educ,Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] Fujian Prov Tumor Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China
[4] Guizhou Prov Peoples Hosp, Dept Radiat Oncol, Guiyang, Peoples R China
[5] Air Force Gen Hosp, Dept Radiat Oncol, Beijing, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Dept Radiat Oncol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7545
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Multicenter Randomized Phase III Trial to Compare Weekly Usage with Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemo-radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Jiang, L.
    Zhu, G.
    Wang, J.
    Shi, A.
    Yu, R.
    Ge, H.
    Li, J.
    Li, X.
    Yan, S.
    Zhang, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E511 - E512
  • [2] A Randomized Phase 2 Trial Comparing Weekly Usage and Every Triweekly Usage of Docetaxel and Platinum in Concurrent Chemoradiation Therapy for Patients With Locally-Advanced Non-Small Cell Lung Cancer
    Zhu, G.
    Geng, J.
    Ge, H.
    Shi, A.
    Yu, R.
    Yang, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S204 - S204
  • [3] Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer
    Choy, H
    Safran, H
    Akerley, W
    Graziano, SL
    Bogart, JA
    Cole, BF
    CLINICAL CANCER RESEARCH, 1998, 4 (08) : 1931 - 1936
  • [4] Treatment Outcome of Locally Advanced Non-small Cell Lung Cancer Patients Who Received Concurrent Chemoradiotherapy with Weekly Paclitaxel
    Kim, Suzy
    Kim, Sung Whan
    Shim, Byoung Yong
    Kim, Chi Hong
    Song, So Hyang
    Meyung Im Ahn
    Cho, Deog Gon
    Cho, Kyu Do
    Yoo, Jinyoung
    Kim, Hoon Kyo
    RADIATION ONCOLOGY JOURNAL, 2006, 24 (04): : 230 - 236
  • [5] Concurrent chemoradiation therapy with weekly paclitaxel for locally advanced non-small cell lung cancer
    Kim, S
    Kim, S
    Shim, B
    Kim, C
    Song, S
    Ahn, M
    Jeong, Y
    Yoo, J
    Kim, H
    LUNG CANCER, 2005, 49 : S380 - S381
  • [6] Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: A phase I study
    Comella, G
    Frasci, G
    Scoppa, G
    Guida, C
    Gravina, A
    Fiore, F
    Casaretti, R
    Daponte, A
    Ruffolo, P
    Comella, P
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 113 - 116
  • [7] Weekly paclitaxel in advanced non-small cell lung cancer
    Chang, AYC
    Rubins, J
    Asbury, R
    Boros, L
    Hui, LF
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 10 - 13
  • [8] A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
    Fady B Geara
    Ali Shamseddine
    Ali Khalil
    Mirna Abboud
    Maya Charafeddine
    Muhieddine Seoud
    Radiation Oncology, 5
  • [9] A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
    Geara, Fady B.
    Shamseddine, Ali
    Khalil, Ali
    Abboud, Mirna
    Charafeddine, Maya
    Seoud, Muhieddine
    RADIATION ONCOLOGY, 2010, 5
  • [10] Randomized phase II trial of weekly squalamine, carboplatin, and paclitaxel as first line therapy for advanced non-small cell lung cancer.
    Rose, V
    Schiller, J
    Wood, A
    Eskander, E
    Holroyd, K
    Desai, A
    Lee, JT
    Ahmed, M
    Kim, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 643S - 643S
12345